Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature
-
Published:2021-05
Issue:4
Volume:50
Page:1713-1728
-
ISSN:0004-0002
-
Container-title:Archives of Sexual Behavior
-
language:en
-
Short-container-title:Arch Sex Behav
Author:
Baldwin AletaORCID, Light Brenda, Allison Waridibo E.ORCID
Abstract
AbstractUsing a socioecological approach, this review describes the peer-reviewed literature on oral pre-exposure prophylaxis (PrEP) among both cisgender (cis women) and transgender women (trans women) in the U.S. A search of the PubMed database and HIV-related conference abstracts generated over 2,200 articles and abstracts. Of these, 103 fulfilled review inclusion criteria. Most of the existing research presents findings on individual-level factors associated with PrEP use such as willingness and perceived barriers. There was far less investigation of factors related to PrEP at more distal ecological levels. Though trans women are at greater risk of HIV infection than cisgender women, less is known about this population group with respect to PrEP despite their inclusion in many major clinical trials. Further, the literature is characterized by a persistent conflation of sex and gender which makes it difficult to accurately assess the reviewed research on HIV prevention and PrEP apart from risk group. Informed by these findings, we highlight specific opportunities to improve access to PrEP and reduce socioecological barriers to PrEP care engagement for cisgender and transgender women.
Publisher
Springer Science and Business Media LLC
Subject
General Psychology,Arts and Humanities (miscellaneous)
Reference129 articles.
1. Amico, K. R., Marcus, J. L., McMahan, V., Liu, A., Koester, K. A., Goicochea, P., & Grant, R. M. (2014). Study product adherence measurement in the iPrEx placebo-controlled trial: Concordance with drug detection. Journal of Acquired Immune Deficiency Syndromes, 66(5), 530–537. 2. Amico, K. R., Mehrotra, M., Avelino-Silva, V. I., McMahan, V., Veloso, V. G., Anderson, P., & iPrEx Study Team. (2016). Self-reported recent PrEP dosing and drug detection in an open label PrEP study. AIDS and Behavior, 20(7), 1535–1540. 3. Auerbach, J., Banyan, A., & Riordan, M. (2012). Will and should women in the U.S. use PrEP? Findings from a focus group study of at-risk, HIV-negative women in Oakland, Memphis, San Diego, and Washington, DC. Paper presented at the International AIDS Conference, Washington, DC. 4. Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care and STDS, 29(2), 102–110. https://doi.org/10.1089/apc.2014.0142. 5. Bailey, J. L., Molino, S. T., Vega, A. D., & Badowski, M. (2017). A review of HIV pre-exposure prophylaxis: The female perspective. Infectious Diseases and Therapy, 6(3), 363–382. https://doi.org/10.1007/s40121-017-0159-9.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|